Vir Biotechnology (VIR) Non Operating Income (2018 - 2026)

Vir Biotechnology has disclosed Non Operating Income across 9 years of filings, most recently posting $6.8 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $6.8 million, down 63.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $48.4 million (up 190.42% YoY), and the FY2025 annual result was $41.6 million, up 1971.14% from the prior year.
• Non Operating Income came in at $6.8 million for Q1 2026 at Vir Biotechnology, down from $41.6 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $41.6 million in Q4 2025 to a low of -$109.2 million in Q4 2022.
• The 5-year median for Non Operating Income is $226000.0 (2025), against an average of -$3.0 million.
• Across the five-year window, Non Operating Income tumbled 1101.06% in 2022 and surged 8327.67% in 2025, its largest moves.
• Vir Biotechnology's Non Operating Income stood at -$109.2 million in 2022, then jumped by 116.72% to $18.3 million in 2023, then sank by 102.77% to -$506000.0 in 2024, then soared by 8327.67% to $41.6 million in 2025, then sank by 83.75% to $6.8 million in 2026.
• The last three Non Operating Income figures came in at $6.8 million (Q1 2026), $41.6 million (Q4 2025), and -$228000.0 (Q3 2025), per Business Quant data.